Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.09 trillion and total revenue of $110.12 billion.
Market Cap
1.09T
Revenue
110.12B
Profits
-39.57B
PE Ratio
n/a
Profit Margin
-35.93%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.98B | 0.36% | 326,560 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.63B | 2.26% | 164,978 | 14.34B |
| 3 | ARGX | argenx SE | 43.57B | 2.44% | 140,975 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.38B | 3.49% | 410,060 | 3.71B |
| 5 | INSM | Insmed Incorporated | 34.76B | 5.19% | 1,295,504 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 32.30B | 2.55% | 70,465 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 27.39B | 2.42% | 883,281 | 2.38B |
| 8 | BNTX | BioNTech SE | 20.99B | 2.59% | 307,885 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.88B | 5.19% | 1,507,178 | 13.31M |
| 10 | RVMD | Revolution Medicines, Inc. | 19.28B | 4.94% | 1,058,608 | - |
| 11 | MRNA | Moderna, Inc. | 19.06B | -0.33% | 2,344,605 | 1.94B |
| 12 | INCY | Incyte Corporation | 18.53B | 3.07% | 378,044 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.22B | 2.63% | 457,073 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.23B | 8.07% | 1,272,201 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.16B | 5.28% | 693,283 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.01B | 4.56% | 224,964 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.33B | 2.92% | 534,474 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.20B | 5.25% | 244,999 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.60B | 2.89% | 457,470 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.13B | 2.13% | 511,512 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.76B | 2.10% | 428,593 | 3.22B |
| 22 | PRAX | Praxis Precision Medicines, Inc. | 8.76B | 13.79% | 361,656 | 7.46M |
| 23 | AXSM | Axsome Therapeutics, Inc. | 8.70B | 5.92% | 285,363 | 638.50M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.66B | 7.29% | 737,014 | 1.09B |
| 25 | PCVX | Vaxcyte, Inc. | 8.31B | 5.04% | 584,919 | - |
| 26 | TECH | Bio-Techne Corporation | 8.06B | -1.06% | 841,348 | 1.22B |
| 27 | ABVX | ABIVAX Société Anonyme | 8.05B | 7.14% | 513,791 | 5.37M |
| 28 | NUVL | Nuvalent, Inc. | 8.03B | 5.61% | 446,207 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.03B | 3.54% | 651,410 | 88.04M |
| 30 | IBRX | ImmunityBio, Inc. | 7.60B | 10.96% | 11,597,815 | 113.29M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.57B | 2.86% | 305,275 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.54B | 4.45% | 158,081 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.78B | 4.44% | 430,560 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | -0.03% | 367,030 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.63B | 4.12% | 215,606 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.24B | 6.29% | 117,253 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.22B | 7.04% | 391,785 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 6.15B | 7.83% | 1,960,499 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | -0.14% | 5,556,852 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 5.84B | 44.85% | 30,932,851 | 15.00M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | 9.59% | 1,021,768 | 189.76M |
| 42 | CGON | CG Oncology, Inc. | 5.77B | 6.80% | 659,782 | 4.04M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.65B | 6.59% | 329,918 | 521.31M |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.60B | 3.08% | 234,098 | 1.73B |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 5.60B | 5.58% | 532,361 | 7.50M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.54B | 11.88% | 2,403,189 | - |
| 47 | CELC | Celcuity Inc. | 5.47B | 4.59% | 124,322 | - |
| 48 | APLS | Apellis Pharmaceuticals, Inc. | 5.15B | 135.75% | 68,460,551 | 1.00B |
| 49 | IMVT | Immunovant, Inc. | 5.01B | 4.50% | 578,817 | - |
| 50 | ERAS | Erasca, Inc. | 4.99B | 7.56% | 1,586,727 | - |
| 51 | CAI | Caris Life Sciences, Inc. | 4.93B | 3.62% | 1,406,479 | 812.03M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.90B | 5.20% | 1,196,513 | 616.29M |
| 53 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.03% | 602,299 | 634.21M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | 7.30% | 789,507 | 2.04M |
| 55 | CRSP | CRISPR Therapeutics AG | 4.42B | 3.74% | 682,025 | 3.51M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.19B | 3.23% | 585,189 | 761.41M |
| 57 | SYRE | Spyre Therapeutics, Inc. | 3.94B | 10.41% | 339,209 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.93B | 2.23% | 82,843 | 268.09M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.79B | 5.69% | 490,822 | 7.70M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.73B | 3.89% | 608,564 | 1.07B |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.69B | 6.85% | 960,809 | - |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | 7.43% | 824,045 | 22.50M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.41B | 5.14% | 220,632 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.34B | 4.22% | 533,166 | 1.03B |
| 65 | GPCR | Structure Therapeutics Inc. | 3.28B | 5.39% | 593,998 | - |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.17B | 5.02% | 56,356 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.00B | 4.78% | 799,382 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.00B | 5.38% | 298,141 | 451.36M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.97B | 2.23% | 192,620 | 588.99M |
| 70 | TNGX | Tango Therapeutics, Inc. | 2.95B | 7.60% | 1,385,041 | 62.38M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.93B | 3.74% | 824,503 | - |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | 5.15% | 356,531 | 218.71M |
| 73 | ALMS | Alumis Inc. | 2.90B | 12.96% | 923,968 | 24.05M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.86B | 8.06% | 819,320 | 376.07M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.77B | 1.94% | 724,614 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.72B | 5.18% | 193,166 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.69B | 5.50% | 721,550 | 490.73M |
| 78 | IMNM | Immunome, Inc. | 2.45B | 12.02% | 1,159,993 | 6.94M |
| 79 | IRON | Disc Medicine, Inc. | 2.40B | 3.50% | 119,136 | - |
| 80 | MANE | Veradermics, Incorporated | 2.39B | 5.00% | 300,642 | - |
| 81 | ORKA | Oruka Therapeutics, Inc. | 2.38B | 5.40% | 439,564 | - |
| 82 | KOD | Kodiak Sciences Inc. | 2.35B | 12.60% | 1,504,121 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.31B | 6.21% | 899,366 | 139.74M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.28B | 4.35% | 1,030,372 | - |
| 85 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 4.49% | 760,480 | 2.20B |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | 15.78% | 1,200,446 | - |
| 87 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 271,585 | 158.18M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.17B | -0.55% | 2,583,931 | 510.17M |
| 89 | AAPG | Ascentage Pharma Group International | 2.16B | 3.11% | 1,937 | 82.08M |
| 90 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 7.70% | 907,226 | 1.55M |
| 91 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | 6.36% | 633,980 | 172.35M |
| 92 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | 20.47% | 1,934,236 | 54.03M |
| 93 | ZLAB | Zai Lab Limited | 2.06B | 2.66% | 274,740 | 460.16M |
| 94 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | 4.20% | 549,293 | 276.98M |
| 95 | TYRA | Tyra Biosciences, Inc. | 2.05B | 9.88% | 580,705 | - |
| 96 | RARE | Ultragenyx Pharmaceutical Inc. | 2.02B | 6.89% | 553,130 | 673.00M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 2.00B | 5.61% | 1,331,128 | 70.85M |
| 98 | GLPG | Galapagos NV | 1.99B | 4.44% | 77,700 | 1.31B |
| 99 | NKTR | Nektar Therapeutics | 1.95B | 4.17% | 588,401 | 55.23M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | 3.86% | 608,098 | 283.06M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.92B | 2.23% | 414,207 | 184.42M |
| 102 | MESO | Mesoblast Limited | 1.91B | 4.11% | 73,725 | 65.38M |
| 103 | PHVS | Pharvaris N.V. | 1.84B | 3.77% | 305,759 | - |
| 104 | ZYME | Zymeworks Inc. | 1.83B | 2.31% | 121,201 | 105.97M |
| 105 | DFTX | Definium Therapeutics, Inc. | 1.83B | 4.69% | 1,144,397 | - |
| 106 | SION | Sionna Therapeutics, Inc. | 1.79B | 8.35% | 113,978 | - |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.77B | 9.66% | 2,118,781 | 51.95M |
| 108 | SLNO | Soleno Therapeutics, Inc. | 1.76B | 11.79% | 1,329,353 | 190.41M |
| 109 | RLAY | Relay Therapeutics, Inc. | 1.75B | 4.60% | 699,830 | 15.36M |
| 110 | INVA | Innoviva, Inc. | 1.73B | 2.05% | 144,871 | 411.33M |
| 111 | CAPR | Capricor Therapeutics, Inc. | 1.73B | 8.17% | 543,201 | 11.13M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.72B | 15.90% | 180,119 | - |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.62B | 7.09% | 672,508 | 83.98M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | 3.94% | 294,651 | 868.45M |
| 115 | ANAB | AnaptysBio, Inc. | 1.61B | 0.96% | 283,773 | 234.60M |
| 116 | VCEL | Vericel Corporation | 1.59B | 2.23% | 339,680 | 276.26M |
| 117 | OCS | Oculis Holding AG | 1.58B | 8.80% | 100,544 | 1.51M |
| 118 | GENB | Generate Biomedicines, Inc. | 1.58B | 7.65% | 112,803 | 31.89M |
| 119 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | 5.11% | 6,383,393 | 74.68M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.55B | 6.22% | 55,649 | - |
| 121 | TRVI | Trevi Therapeutics, Inc. | 1.52B | 5.50% | 276,372 | - |
| 122 | MAZE | Maze Therapeutics, Inc. | 1.50B | 3.76% | 402,108 | 2.50M |
| 123 | NBTX | Nanobiotix S.A. | 1.50B | -3.87% | 54,166 | 11.93M |
| 124 | IMCR | Immunocore Holdings plc | 1.49B | 0.58% | 289,056 | 400.02M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.46B | 6.35% | 1,727,344 | 67.67M |
| 126 | ARDX | Ardelyx, Inc. | 1.45B | 6.58% | 2,241,147 | 407.32M |
| 127 | NUVB | Nuvation Bio Inc. | 1.44B | 3.95% | 1,274,718 | 62.90M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.43B | 8.41% | 159,800 | - |
| 129 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | 4.07% | 4,951,341 | 263.50M |
| 130 | MBX | MBX Biosciences, Inc. | 1.42B | 10.85% | 193,130 | - |
| 131 | VIR | Vir Biotechnology, Inc. | 1.41B | 4.02% | 306,667 | 68.56M |
| 132 | SVRA | Savara Inc. | 1.37B | 6.73% | 494,600 | - |
| 133 | WVE | Wave Life Sciences Ltd. | 1.34B | 7.40% | 7,228,496 | 42.73M |
| 134 | MLTX | MoonLake Immunotherapeutics | 1.33B | 9.63% | 1,197,224 | - |
| 135 | IMTX | Immatics N.V. | 1.30B | 4.62% | 53,600 | 56.67M |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30B | 4.89% | 435,258 | 123.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.29B | 3.97% | 1,230,828 | 4.09M |
| 138 | PGEN | Precigen, Inc. | 1.28B | 11.69% | 4,922,010 | 9.68M |
| 139 | NVAX | Novavax, Inc. | 1.28B | -2.60% | 2,866,655 | 1.12B |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 3.53% | 512,849 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.27B | 1.52% | 270,854 | - |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | 7.75% | 577,987 | - |
| 143 | BHVN | Biohaven Ltd. | 1.26B | 3.46% | 1,511,797 | - |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | 7.25% | 885,750 | 9.77M |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | 7.01% | 443,864 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.12B | 5.73% | 186,328 | 5.64M |
| 147 | ZBIO | Zenas BioPharma, Inc. | 1.12B | 3.02% | 622,065 | 10.00M |
| 148 | PHAR | Pharming Group N.V. | 1.11B | 2.81% | 5,335 | 376.13M |
| 149 | EYPT | EyePoint, Inc. | 1.07B | 8.02% | 477,891 | 31.37M |
| 150 | SEPN | Septerna, Inc. | 1.07B | 1.85% | 79,523 | 45.95M |
| 151 | IVA | Inventiva S.A. | 1.05B | 1.46% | 621,109 | 19.93M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.03B | 3.96% | 1,706,064 | 75.13M |
| 153 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | 8.99% | 504,734 | 73.62M |
| 154 | AVBP | ArriVent BioPharma, Inc. | 1.02B | 9.95% | 200,894 | - |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 998.38M | 3.39% | 656,162 | 291.85M |
| 156 | CTMX | CytomX Therapeutics, Inc. | 996.58M | 4.54% | 1,152,657 | 76.20M |
| 157 | QURE | uniQure N.V. | 988.59M | 7.33% | 580,232 | 16.10M |
| 158 | AKTS | Aktis Oncology, Inc. | 953.54M | 9.76% | 352,405 | 6.50M |
| 159 | INBX | Inhibrx Biosciences, Inc. | 943.32M | 7.85% | 44,137 | 1.30M |
| 160 | GERN | Geron Corporation | 938.40M | 3.90% | 6,805,583 | 183.88M |
| 161 | CMPX | Compass Therapeutics, Inc. | 916.65M | -0.20% | 1,445,661 | 850.00K |
| 162 | URGN | UroGen Pharma Ltd. | 883.58M | 6.76% | 197,262 | 109.79M |
| 163 | XNCR | Xencor, Inc. | 876.40M | 5.29% | 493,720 | 125.58M |
| 164 | ANNX | Annexon, Inc. | 875.39M | 9.98% | 2,612,294 | - |
| 165 | GHRS | GH Research PLC | 870.27M | 7.67% | 113,434 | - |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 869.15M | 4.75% | 263,468 | 175.11M |
| 167 | FTRE | Fortrea Holdings Inc. | 867.68M | 4.62% | 393,775 | 2.72B |
| 168 | ABUS | Arbutus Biopharma Corporation | 860.10M | 2.33% | 466,245 | 14.08M |
| 169 | CGEM | Cullinan Therapeutics, Inc. | 850.39M | 4.69% | 237,615 | - |
| 170 | MPLT | MapLight Therapeutics, Inc. | 842.62M | 2.30% | 50,295 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 832.79M | 5.07% | 391,778 | 10.00M |
| 172 | EVMN | Evommune, Inc. | 829.50M | 4.68% | 97,299 | 13.00M |
| 173 | TBPH | Theravance Biopharma, Inc. | 826.46M | 5.18% | 304,610 | 107.46M |
| 174 | SGP | SpyGlass Pharma, Inc. | 822.44M | 5.63% | 36,822 | - |
| 175 | SPRY | ARS Pharmaceuticals, Inc. | 781.47M | 0.70% | 503,265 | 84.28M |
| 176 | TENX | Tenax Therapeutics, Inc. | 776.64M | 10.21% | 241,721 | - |
| 177 | SANA | Sana Biotechnology, Inc. | 747.23M | 4.48% | 1,174,660 | - |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 739.88M | 2.87% | 3,465,160 | - |
| 179 | MNKD | MannKind Corporation | 734.82M | 0.63% | 1,281,316 | 348.97M |
| 180 | OMER | Omeros Corporation | 732.40M | 5.30% | 521,572 | - |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 731.36M | -1.22% | 1,008,201 | 185.74M |
| 182 | KURA | Kura Oncology, Inc. | 722.54M | 5.82% | 390,440 | 67.48M |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 721.90M | 3.92% | 62,955 | - |
| 184 | ANRO | Alto Neuroscience, Inc. | 712.70M | 11.66% | 358,438 | - |
| 185 | VOR | Vor Biopharma Inc. | 704.18M | 15.37% | 1,249,715 | - |
| 186 | RLMD | Relmada Therapeutics, Inc. | 696.47M | 4.08% | 766,479 | - |
| 187 | JBIO | Jade Biosciences, Inc. | 690.92M | 5.66% | 67,860 | - |
| 188 | SLDB | Solid Biosciences Inc. | 689.72M | 8.01% | 657,434 | - |
| 189 | MGTX | MeiraGTx Holdings plc | 687.41M | 4.33% | 389,643 | 81.39M |
| 190 | ARVN | Arvinas, Inc. | 685.02M | 5.21% | 326,517 | 262.60M |
| 191 | DRUG | Bright Minds Biosciences Inc. | 670.65M | 6.65% | 68,751 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 663.90M | 3.81% | 99,012 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.82M | 2.98% | 669,435 | 49.80M |
| 194 | REPL | Replimune Group, Inc. | 644.07M | 8.33% | 686,899 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 633.72M | 1.46% | 31,361 | 116.59M |
| 196 | DRTS | Alpha Tau Medical Ltd. | 616.07M | 6.87% | 107,387 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 615.65M | 4.67% | 77,563 | - |
| 198 | PRME | Prime Medicine, Inc. | 597.64M | 7.14% | 860,787 | 4.63M |
| 199 | OCGN | Ocugen, Inc. | 596.39M | 0.86% | 3,897,297 | 4.41M |
| 200 | CBIO | Crescent Biopharma, Inc. | 588.05M | 6.53% | 68,086 | 10.84M |
| 201 | EIKN | Eikon Therapeutics, Inc. | 578.17M | 10.64% | 180,746 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 578.04M | 6.63% | 49,497 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 577.75M | 6.76% | 1,938,172 | 22.00K |
| 204 | MDXG | MiMedx Group, Inc. | 573.47M | - | 766,983 | 418.63M |
| 205 | VALN | Valneva SE | 556.03M | 1.68% | 254,023 | 205.07M |
| 206 | ZURA | Zura Bio Limited | 552.21M | 2.46% | 285,904 | - |
| 207 | YDES | YD Bio Limited | 548.49M | -3.70% | 5,904 | 510.36K |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 538.97M | 4.56% | 275,744 | 106.47M |
| 209 | CRMD | CorMedix Inc. | 532.01M | 2.44% | 275,995 | 311.71M |
| 210 | PROK | ProKidney Corp. | 531.37M | 8.64% | 700,210 | 893.00K |
| 211 | PRTA | Prothena Corporation plc | 520.03M | 4.43% | 186,692 | 9.68M |
| 212 | AGMB | AgomAb Therapeutics NV | 520.02M | 8.22% | 35,471 | - |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 511.50M | 5.44% | 651,545 | 7.83M |
| 214 | FULC | Fulcrum Therapeutics, Inc. | 499.50M | 13.98% | 2,463,626 | 80.00M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 492.68M | 3.69% | 57,758 | 294.28M |
| 216 | VTVT | vTv Therapeutics Inc. | 489.06M | 7.38% | 31,353 | 17.00K |
| 217 | KYTX | Kyverna Therapeutics, Inc. | 487.87M | 6.46% | 274,897 | - |
| 218 | CTNM | Contineum Therapeutics, Inc. | 486.12M | 4.49% | 104,445 | - |
| 219 | UPB | Upstream Bio, Inc. | 484.34M | 1.37% | 242,477 | 2.85M |
| 220 | FBRX | Forte Biosciences, Inc. | 474.32M | 1.06% | 104,270 | - |
| 221 | ADCT | ADC Therapeutics SA | 472.61M | 2.20% | 229,760 | 81.36M |
| 222 | NAUT | Nautilus Biotechnology, Inc. | 470.82M | 8.45% | 132,736 | - |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 468.65M | 7.12% | 226,913 | 85.21M |
| 224 | LRMR | Larimar Therapeutics, Inc. | 467.47M | 4.41% | 442,531 | - |
| 225 | LYEL | Lyell Immunopharma, Inc. | 466.84M | 3.84% | 31,327 | 36.00K |
| 226 | VSTM | Verastem, Inc. | 465.53M | 9.28% | 2,109,260 | 30.91M |
| 227 | ABSI | Absci Corporation | 453.71M | 7.43% | 1,393,502 | 2.80M |
| 228 | ENGN | enGene Holdings Inc. | 447.49M | 8.09% | 48,053 | - |
| 229 | TRDA | Entrada Therapeutics, Inc. | 444.24M | 4.84% | 46,637 | 25.42M |
| 230 | STTK | Shattuck Labs, Inc. | 440.84M | 3.36% | 94,609 | 1.00M |
| 231 | IMMX | Immix Biopharma, Inc. | 431.66M | -5.01% | 390,199 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 429.56M | 1.65% | 38,134 | 72.30M |
| 233 | RGNX | REGENXBIO Inc. | 424.26M | 5.79% | 232,304 | 170.44M |
| 234 | LXEO | Lexeo Therapeutics, Inc. | 420.07M | 7.59% | 418,559 | - |
| 235 | AVIR | Atea Pharmaceuticals, Inc. | 419.08M | 3.54% | 85,838 | - |
| 236 | AURA | Aura Biosciences, Inc. | 412.17M | 3.63% | 126,345 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.80M | 6.13% | 26,228 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 409.87M | 2.66% | 22,654 | 102.48M |
| 239 | IPSC | Century Therapeutics, Inc. | 396.29M | 8.62% | 382,870 | 109.16M |
| 240 | ALT | Altimmune, Inc. | 395.52M | 5.56% | 1,177,178 | 41.00K |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 391.89M | -0.30% | 378,394 | 216.11M |
| 242 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | 5.44% | 385,699 | 14.56M |
| 243 | MNPR | Monopar Therapeutics Inc. | 385.12M | 8.14% | 66,196 | - |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 381.08M | 1.89% | 2,176,151 | - |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 380.04M | 4.76% | 153,673 | 35.11M |
| 246 | PLYX | Polaryx Therapeutics, Inc. | 376.85M | 20.42% | 205,793 | - |
| 247 | AUTL | Autolus Therapeutics plc | 371.27M | 9.84% | 2,035,171 | 51.13M |
| 248 | XOMA | XOMA Royalty Corporation | 365.93M | 1.52% | 51,980 | 52.15M |
| 249 | IVVD | Invivyd, Inc. | 358.90M | 6.72% | 728,683 | 53.43M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 356.65M | 0.90% | 25,464 | 66.98M |
| 251 | BNTC | Benitec Biopharma Inc. | 356.25M | 3.38% | 62,734 | - |
| 252 | CADL | Candel Therapeutics, Inc. | 355.25M | 8.26% | 500,332 | - |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 352.39M | -1.51% | 177,763 | - |
| 254 | NAGE | Niagen Bioscience, Inc. | 349.88M | 1.87% | 217,447 | 129.42M |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 346.92M | 8.76% | 447,250 | 170.16M |
| 256 | PRTC | PureTech Health plc | 346.23M | 2.31% | 748 | 6.39M |
| 257 | NMRA | Neumora Therapeutics, Inc. | 337.33M | 2.85% | 1,714,122 | - |
| 258 | ARMP | Armata Pharmaceuticals, Inc. | 335.94M | 6.76% | 8,300 | 4.90M |
| 259 | CLYM | Climb Bio, Inc. | 332.94M | 6.57% | 97,236 | - |
| 260 | IMRX | Immuneering Corporation | 330.38M | 4.71% | 236,130 | - |
| 261 | SRZN | Surrozen, Inc. | 326.22M | 3.46% | 124,096 | 3.48M |
| 262 | PBYI | Puma Biotechnology, Inc. | 320.52M | 2.77% | 87,084 | 228.37M |
| 263 | BCYC | Bicycle Therapeutics plc | 319.27M | 5.53% | 144,901 | 72.59M |
| 264 | IRD | Opus Genetics, Inc. | 318.75M | 2.99% | 165,637 | 14.20M |
| 265 | AVTX | Avalo Therapeutics, Inc. | 317.90M | 0.14% | 374,209 | 59.00K |
| 266 | GLSI | Greenwich LifeSciences, Inc. | 317.68M | 6.70% | 60,657 | - |
| 267 | NGNE | Neurogene Inc. | 309.77M | 3.06% | 26,951 | 925.00K |
| 268 | NGEN | NervGen Pharma Corp. | 299.48M | 0.80% | 82,312 | - |
| 269 | RZLT | Rezolute, Inc. | 299.15M | 1.05% | 497,845 | - |
| 270 | OVID | Ovid Therapeutics Inc. | 291.44M | 4.74% | 462,882 | 7.25M |
| 271 | CABA | Cabaletta Bio, Inc. | 288.33M | 4.86% | 805,238 | - |
| 272 | LENZ | LENZ Therapeutics, Inc. | 284.70M | 9.53% | 892,938 | 19.09M |
| 273 | PRLD | Prelude Therapeutics Incorporated | 283.09M | 11.73% | 106,895 | 12.14M |
| 274 | FHTX | Foghorn Therapeutics Inc. | 281.76M | 8.60% | 70,081 | 30.91M |
| 275 | AVXL | Anavex Life Sciences Corp. | 278.94M | 6.74% | 827,014 | - |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 276.94M | 2.85% | 219,232 | 1.00 |
| 277 | TARA | Protara Therapeutics, Inc. | 275.29M | 4.95% | 196,204 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 269.86M | 1.59% | 61,425 | 114.70K |
| 279 | NERV | Minerva Neurosciences, Inc. | 268.30M | 3.85% | 41,303 | - |
| 280 | ALXO | ALX Oncology Holdings Inc. | 266.51M | 6.02% | 142,271 | - |
| 281 | NBP | NovaBridge Biosciences | 265.17M | 2.68% | 507,864 | - |
| 282 | ACIU | AC Immune SA | 264.87M | 4.30% | 42,186 | 4.51M |
| 283 | ANL | Adlai Nortye Ltd. | 262.91M | 7.79% | 263,542 | -1.35M |
| 284 | PALI | Palisade Bio, Inc. | 257.12M | -12.92% | 7,188,662 | - |
| 285 | CCCC | C4 Therapeutics, Inc. | 254.19M | 10.85% | 845,869 | 35.95M |
| 286 | CHRS | Coherus Oncology, Inc. | 251.82M | 5.00% | 291,447 | 42.17M |
| 287 | ABEO | Abeona Therapeutics Inc. | 249.87M | 3.55% | 443,423 | 5.82M |
| 288 | SLGL | Sol-Gel Technologies Ltd. | 244.52M | 9.13% | 27,964 | 19.39M |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 243.57M | 2.26% | 31,758 | 33.48M |
| 290 | SLN | Silence Therapeutics plc | 243.25M | 3.41% | 135,178 | 559.00K |
| 291 | CNTX | Context Therapeutics Inc. | 239.35M | 6.33% | 185,657 | - |
| 292 | ALEC | Alector, Inc. | 235.07M | 5.45% | 106,544 | 21.05M |
| 293 | EDIT | Editas Medicine, Inc. | 234.89M | 7.62% | 907,740 | 40.52M |
| 294 | CLLS | Cellectis S.A. | 233.21M | 4.84% | 11,820 | 79.59M |
| 295 | HELP | Cybin Inc. | 229.66M | 6.25% | 406,218 | - |
| 296 | VYGR | Voyager Therapeutics, Inc. | 228.27M | -1.03% | 243,296 | 40.37M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 227.93M | 9.75% | 22,951 | 3.50M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 227.90M | 10.70% | 846,183 | - |
| 299 | AKTX | Akari Therapeutics, Plc | 224.76M | 2.58% | 19,446 | - |
| 300 | OABI | OmniAb, Inc. | 223.69M | -0.96% | 112,898 | 18.67M |
| 301 | ENLV | Enlivex Ltd. | 223.28M | 4.51% | 224,375 | - |
| 302 | KROS | Keros Therapeutics, Inc. | 216.10M | 2.62% | 114,628 | 244.06M |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 210.33M | 7.25% | 417,801 | 82.03M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 208.92M | 5.03% | 40,159 | 44.64M |
| 305 | MDWD | MediWound Ltd. | 204.91M | 3.18% | 31,733 | 16.96M |
| 306 | NVCT | Nuvectis Pharma, Inc. | 202.66M | 2.14% | 12,837 | - |
| 307 | CGEN | Compugen Ltd. | 200.45M | 6.53% | 187,854 | 72.76M |
| 308 | ELTX | Elicio Therapeutics, Inc. | 194.91M | 5.11% | 39,844 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 187.09M | 9.48% | 263,037 | 13.11M |
| 310 | MGNX | MacroGenics, Inc. | 181.13M | 3.26% | 119,242 | 149.50M |
| 311 | ADAG | Adagene Inc. | 179.57M | 0.53% | 16,486 | 103.20K |
| 312 | CRBU | Caribou Biosciences, Inc. | 178.30M | 7.27% | 1,059,869 | 11.16M |
| 313 | GALT | Galectin Therapeutics Inc. | 174.08M | 5.06% | 76,485 | - |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 172.02M | 2.15% | 491,948 | 52.74M |
| 315 | PRQR | ProQR Therapeutics N.V. | 170.16M | 6.95% | 368,545 | 19.19M |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 169.70M | 7.31% | 139,174 | - |
| 317 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.90M | 9.42% | 104,721 | - |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 163.83M | 5.10% | 89,528 | 2.80M |
| 319 | SGMT | Sagimet Biosciences Inc. | 163.25M | 10.11% | 157,107 | - |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 162.28M | 2.27% | 239,748 | - |
| 321 | KRRO | Korro Bio, Inc. | 160.52M | 8.27% | 212,594 | 6.39M |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 160.00M | 3.35% | 101,640 | 7.15M |
| 323 | TLSA | Tiziana Life Sciences Ltd | 156.98M | -0.81% | 79,241 | - |
| 324 | MENS | Jyong Biotech Ltd. | 154.57M | 5.79% | 92,493 | - |
| 325 | ACHV | Achieve Life Sciences, Inc. | 153.86M | 8.24% | 515,337 | - |
| 326 | CNTB | Connect Biopharma Holdings Limited | 152.06M | -6.20% | 212,221 | 762.00K |
| 327 | ARTV | Artiva Biotherapeutics, Inc. | 149.54M | 11.01% | 65,063 | 251.00K |
| 328 | ZNTL | Zentalis Pharmaceuticals, Inc. | 149.25M | 7.71% | 190,487 | 26.87M |
| 329 | NKTX | Nkarta, Inc. | 149.00M | 4.50% | 156,084 | - |
| 330 | MIST | Milestone Pharmaceuticals Inc. | 147.79M | 19.31% | 2,147,505 | 1.55M |
| 331 | CBUS | Cibus, Inc. | 147.01M | 6.04% | 259,904 | 3.64M |
| 332 | MOLN | Molecular Partners AG | 146.79M | 0.64% | 505 | 856.30K |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 146.11M | 8.60% | 1,673,269 | - |
| 334 | CDXS | Codexis, Inc. | 145.85M | 5.59% | 309,382 | 70.39M |
| 335 | HRTX | Heron Therapeutics, Inc. | 144.91M | 3.04% | 263,407 | 154.90M |
| 336 | DTIL | Precision BioSciences, Inc. | 144.76M | 3.51% | 63,376 | 34.26M |
| 337 | IMUX | Immunic, Inc. | 143.51M | 6.80% | 957,582 | - |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 140.34M | 6.87% | 352,219 | - |
| 339 | NTHI | NeOnc Technologies Holdings, Inc. | 137.11M | -2.14% | 3,547 | 59.99K |
| 340 | FATE | Fate Therapeutics, Inc. | 136.61M | 3.98% | 297,434 | 6.65M |
| 341 | SPRO | Spero Therapeutics, Inc. | 132.86M | 2.46% | 338,162 | 66.80M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 132.54M | 1.52% | 20,458 | 2.00M |
| 343 | HUMA | Humacyte, Inc. | 130.19M | 2.07% | 4,193,478 | 2.04M |
| 344 | KLRS | Kalaris Therapeutics, Inc. | 129.54M | 6.60% | 8,964 | - |
| 345 | KPTI | Karyopharm Therapeutics Inc. | 128.05M | 7.17% | 254,956 | 146.07M |
| 346 | AGEN | Agenus Inc. | 127.87M | 2.78% | 195,901 | 114.20M |
| 347 | ANTX | AN2 Therapeutics, Inc. | 125.79M | 1.16% | 123,474 | - |
| 348 | EQ | Equillium, Inc. | 123.29M | 11.43% | 112,292 | 4.39M |
| 349 | BDTX | Black Diamond Therapeutics, Inc. | 120.88M | 3.94% | 215,238 | 70.00M |
| 350 | INO | Inovio Pharmaceuticals, Inc. | 118.84M | 2.99% | 467,411 | 65.34K |
| 351 | PMN | ProMIS Neurosciences, Inc. | 117.30M | 1.55% | 16,037 | - |
| 352 | ACOG | Alpha Cognition Inc. | 115.67M | - | 283,091 | 10.22M |
| 353 | IPHA | Innate Pharma S.A. | 115.51M | 1.02% | 6,778 | 10.57M |
| 354 | BMEA | Biomea Fusion, Inc. | 112.06M | 17.42% | 2,568,262 | - |
| 355 | CRDF | Cardiff Oncology, Inc. | 109.73M | 3.55% | 338,962 | 593.00K |
| 356 | PEPG | PepGen Inc. | 105.06M | -64.07% | 18,749,894 | - |
| 357 | GNLX | Genelux Corporation | 102.94M | 0.87% | 58,024 | 8.00K |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 102.61M | 1.49% | 914,699 | - |
| 359 | HURA | TuHURA Biosciences, Inc. | 102.31M | -2.60% | 115,766 | - |
| 360 | SEER | Seer, Inc. | 94.50M | -0.30% | 97,966 | 16.58M |
| 361 | TTRX | Turn Therapeutics Inc. | 93.93M | -0.93% | 8,626 | - |
| 362 | QTTB | Q32 Bio Inc. | 92.75M | 7.46% | 137,220 | 53.74M |
| 363 | COYA | Coya Therapeutics, Inc. | 91.48M | 3.17% | 36,532 | 7.95M |
| 364 | LONA | LeonaBio, Inc. | 91.40M | 5.67% | 6,106 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 90.65M | 4.65% | 434,954 | - |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 87.62M | 7.15% | 14,928 | 35.58M |
| 367 | PYXS | Pyxis Oncology, Inc. | 87.34M | 9.45% | 207,605 | 13.86M |
| 368 | ANIX | Anixa Biosciences, Inc. | 87.17M | 4.00% | 79,966 | - |
| 369 | MCRB | Seres Therapeutics, Inc. | 86.18M | 2.16% | 7,817 | 789.00K |
| 370 | SPRB | Spruce Biosciences, Inc. | 85.07M | 5.93% | 8,305 | 697.00K |
| 371 | KZIA | Kazia Therapeutics Limited | 84.56M | 1.23% | 104,328 | 1.27M |
| 372 | FBIO | Fortress Biotech, Inc. | 84.27M | 0.56% | 491,010 | 62.30M |
| 373 | PYPD | PolyPid Ltd. | 84.06M | 4.63% | 71,991 | - |
| 374 | VANI | Vivani Medical, Inc. | 83.40M | 5.04% | 109,377 | - |
| 375 | CSBR | Champions Oncology, Inc. | 82.82M | 2.12% | 1,530 | 57.95M |
| 376 | MAIA | MAIA Biotechnology, Inc. | 82.51M | 3.82% | 536,699 | - |
| 377 | OKYO | OKYO Pharma Limited | 82.39M | 3.97% | 37,410 | - |
| 378 | SGMO | Sangamo Therapeutics, Inc. | 80.51M | -29.52% | 17,310,049 | 32.88M |
| 379 | GANX | Gain Therapeutics, Inc. | 80.47M | 5.83% | 160,446 | - |
| 380 | NRXS | NeurAxis, Inc. | 79.32M | 7.26% | 90,988 | 3.57M |
| 381 | FLNA | Filana Therapeutics, Inc. | 79.22M | 1.23% | 167,143 | - |
| 382 | AARD | Aardvark Therapeutics, Inc. | 77.45M | -2.47% | 144,143 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 76.92M | 1.07% | 804,959 | 1.63M |
| 384 | GOSS | Gossamer Bio, Inc. | 76.35M | 1.66% | 2,889,121 | 48.47M |
| 385 | PLRX | Pliant Therapeutics, Inc. | 76.16M | 4.68% | 405,114 | - |
| 386 | ATYR | aTyr Pharma, Inc. | 74.53M | 4.00% | 370,939 | 190.00K |
| 387 | PTHS | Pelthos Therapeutics Inc. | 72.14M | 2.38% | 2,993 | 16.80M |
| 388 | ACET | Adicet Bio, Inc. | 70.78M | 7.77% | 34,511 | - |
| 389 | BYSI | BeyondSpring Inc. | 70.73M | 6.17% | 1,203 | 1.88M |
| 390 | NRXP | NRx Pharmaceuticals, Inc. | 70.69M | 2.39% | 188,237 | 1.23M |
| 391 | GUTS | Fractyl Health, Inc. | 70.28M | 3.75% | 805,951 | 3.00K |
| 392 | XBIT | XBiotech Inc. | 70.12M | 1.32% | 16,577 | - |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 69.45M | 4.10% | 6,822 | 1.36M |
| 394 | CING | Cingulate Inc. | 69.31M | 2.05% | 224,268 | - |
| 395 | GRCE | Grace Therapeutics, Inc. | 67.93M | 0.69% | 160,725 | - |
| 396 | MNOV | MediciNova, Inc. | 66.94M | - | 20,321 | 409.66K |
| 397 | DWTX | Dogwood Therapeutics, Inc. | 65.63M | 10.39% | 25,912 | - |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 65.60M | 0.82% | 124,834 | - |
| 399 | IBO | Impact BioMedical Inc. | 64.74M | 2.56% | 116,332 | 32.00K |
| 400 | IBIO | iBio, Inc. | 64.42M | 9.06% | 410,146 | 300.00K |
| 401 | CGTX | Cognition Therapeutics, Inc. | 63.44M | 19.41% | 1,540,461 | - |
| 402 | EXOZ | eXoZymes, Inc. | 62.58M | 2.05% | 2,676 | -700.00 |
| 403 | ANVS | Annovis Bio, Inc. | 62.52M | 9.70% | 282,153 | - |
| 404 | IFRX | InflaRx N.V. | 62.47M | 3.90% | 85,871 | 34.44K |
| 405 | ATHE | Alterity Therapeutics Limited | 59.60M | -3.36% | 2,445 | 4.43M |
| 406 | ACTU | Actuate Therapeutics, Inc. | 59.27M | 9.17% | 28,611 | - |
| 407 | ICCC | ImmuCell Corporation | 59.25M | 1.87% | 7,731 | 27.64M |
| 408 | TIL | Instil Bio, Inc. | 56.90M | 5.27% | 15,219 | - |
| 409 | LPCN | Lipocine Inc. | 56.43M | 1.98% | 53,470 | 1.98M |
| 410 | HYFT | MindWalk Holdings Corp. | 56.37M | 11.27% | 90,467 | 20.70M |
| 411 | TCRX | TScan Therapeutics, Inc. | 55.78M | 4.25% | 120,114 | 10.33M |
| 412 | KZR | Kezar Life Sciences, Inc. | 54.92M | - | 84,384 | - |
| 413 | OKUR | OnKure Therapeutics, Inc. | 54.69M | 5.54% | 254,040 | - |
| 414 | IMA | ImageneBio, Inc. | 52.79M | -5.60% | 37,471 | 800.00K |
| 415 | MREO | Mereo BioPharma Group plc | 52.75M | 4.59% | 510,593 | 500.00K |
| 416 | ACRV | Acrivon Therapeutics, Inc. | 52.69M | 5.43% | 193,357 | - |
| 417 | RADX | Radiopharm Theranostics Limited | 50.98M | -0.23% | 12,073 | 10.86M |
| 418 | XLO | Xilio Therapeutics, Inc. | 50.60M | 6.25% | 19,058 | 43.77M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 49.85M | 4.74% | 64,566 | 25.21M |
| 420 | OSTX | OS Therapies Incorporated | 47.89M | 2.25% | 241,467 | - |
| 421 | ENTX | Entera Bio Ltd. | 47.69M | 4.00% | 42,605 | 42.00K |
| 422 | IMMP | Immutep Limited | 47.44M | 0.09% | 438,866 | 5.28M |
| 423 | INKT | MiNK Therapeutics, Inc. | 47.25M | -4.33% | 66,602 | - |
| 424 | EDSA | Edesa Biotech, Inc. | 46.67M | 4.88% | 106,249 | - |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.25M | - | 7,130 | 170.00K |
| 426 | RNXT | RenovoRx, Inc. | 45.09M | -6.54% | 506,212 | 1.12M |
| 427 | ESLA | Estrella Immunopharma, Inc. | 44.80M | 1.94% | 3,110 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 44.73M | 10.19% | 24,652 | 2.19M |
| 429 | RLYB | Rallybio Corporation | 43.69M | 2.74% | 58,981 | 858.00K |
| 430 | ATOS | Atossa Therapeutics, Inc. | 43.06M | 6.16% | 17,208 | - |
| 431 | NTRB | Nutriband Inc. | 43.03M | 2.31% | 6,053 | 2.28M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 41.43M | 5.70% | 63,315 | - |
| 433 | LITS | Lite Strategy, Inc. | 40.36M | 6.73% | 374,666 | - |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 40.06M | 3.44% | 192,571 | 1.14M |
| 435 | NBY | NovaBay Pharmaceuticals, Inc. | 38.74M | 7.78% | 119,078 | 10.30M |
| 436 | NXTC | NextCure, Inc. | 38.35M | 8.79% | 23,549 | - |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 37.78M | 6.94% | 21,646 | 120.77M |
| 438 | CELU | Celularity Inc. | 37.20M | 2.38% | 27,961 | 40.58M |
| 439 | PTN | Palatin Technologies, Inc. | 36.77M | 2.73% | 2,085 | 8.96M |
| 440 | RNTX | Rein Therapeutics Inc. | 36.31M | 1.97% | 17,385 | - |
| 441 | VERU | Veru Inc. | 35.63M | 4.23% | 14,124 | 16.89M |
| 442 | CRVO | CervoMed Inc. | 34.91M | 4.14% | 14,585 | 4.01M |
| 443 | APLM | Apollomics, Inc. | 34.10M | -4.91% | 2,616 | 6.93M |
| 444 | SNSE | Sensei Biotherapeutics, Inc. | 33.74M | 6.09% | 83,269 | - |
| 445 | PLUR | Pluri Inc. | 33.37M | - | 293 | 1.34M |
| 446 | PDSB | PDS Biotechnology Corporation | 31.28M | 6.54% | 622,517 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 30.26M | -2.01% | 72,547 | 90.00K |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 30.11M | 0.31% | 16,792 | - |
| 449 | HYPD | Hyperion DeFi, Inc. | 30.02M | 4.47% | 54,088 | 813.46K |
| 450 | EVAX | Evaxion A/S | 29.73M | -5.44% | 14,410 | 7.53M |
| 451 | INMB | INmune Bio Inc. | 29.51M | -2.63% | 283,033 | 50.00K |
| 452 | BCTX | BriaCell Therapeutics Corp. | 29.37M | 1.21% | 70,148 | - |
| 453 | LGVN | Longeveron Inc. | 28.99M | 6.41% | 295,355 | 1.20M |
| 454 | PSTV | Plus Therapeutics, Inc. | 28.49M | -22.60% | 17,519,197 | 5.21M |
| 455 | DYAI | Dyadic International, Inc. | 27.88M | 4.81% | 36,978 | 3.09M |
| 456 | XCUR | Exicure, Inc. | 27.70M | -2.84% | 7,739 | 500.00K |
| 457 | KYNB | Kyntra Bio, Inc. | 27.40M | 4.80% | 8,729 | 6.44M |
| 458 | LIXT | Lixte Biotechnology Holdings, Inc. | 27.10M | -0.64% | 2,613 | - |
| 459 | SER | Serina Therapeutics, Inc. | 26.23M | 18.33% | 711,254 | 130.00K |
| 460 | DARE | Daré Bioscience, Inc. | 25.92M | -2.73% | 34,401 | 1.03M |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 25.71M | 5.32% | 35,505 | - |
| 462 | IGC | IGC Pharma, Inc. | 25.23M | 3.05% | 130,682 | 1.11M |
| 463 | CVM | CEL-SCI Corporation | 24.93M | 0.33% | 9,696 | - |
| 464 | AEON | AEON Biopharma, Inc. | 24.92M | -0.45% | 43,375 | - |
| 465 | BOLD | Boundless Bio, Inc. | 24.54M | 0.92% | 49,666 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 24.47M | -2.34% | 239,618 | - |
| 467 | PASG | Passage Bio, Inc. | 24.20M | 22.09% | 52,656 | - |
| 468 | SNTI | Senti Biosciences, Inc. | 24.09M | 0.22% | 46,056 | 22.00K |
| 469 | JSPR | Jasper Therapeutics, Inc. | 24.06M | -4.47% | 467,261 | - |
| 470 | ABVC | ABVC BioPharma, Inc. | 23.84M | 6.11% | 50,454 | 797.92K |
| 471 | BRNS | Barinthus Biotherapeutics plc | 22.96M | 2.18% | 2,155 | 14.97M |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 22.58M | 4.45% | 129,521 | 789.00K |
| 473 | TPST | Tempest Therapeutics, Inc. | 22.45M | 5.92% | 110,587 | - |
| 474 | CUE | Cue Biopharma, Inc. | 22.27M | 0.88% | 252,600 | 27.47M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 22.10M | 4.06% | 24,406 | 14.99M |
| 476 | OTLK | Outlook Therapeutics, Inc. | 21.91M | 4.18% | 1,260,044 | 205.70K |
| 477 | MRKR | Marker Therapeutics, Inc. | 21.34M | 3.23% | 36,742 | 3.55M |
| 478 | CRIS | Curis, Inc. | 21.19M | 3.45% | 154,303 | 9.44M |
| 479 | PLRZ | Polyrizon Ltd. | 20.08M | 6.06% | 8,997 | - |
| 480 | LEXX | Lexaria Bioscience Corp. | 19.86M | 2.31% | 23,100 | 522.00K |
| 481 | NNVC | NanoViricides, Inc. | 19.76M | 5.16% | 36,439 | - |
| 482 | VYNE | VYNE Therapeutics Inc. | 19.63M | 0.20% | 49,600 | 570.00K |
| 483 | SKYE | Skye Bioscience, Inc. | 19.38M | -2.02% | 92,869 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.24M | 19.81% | 1,191,234 | 3.94M |
| 485 | TVGN | Tevogen Bio Holdings Inc. | 17.41M | 0.23% | 20,237 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 17.21M | 2.88% | 47,843 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.07M | 3.41% | 13,608 | - |
| 488 | LTRN | Lantern Pharma Inc. | 16.16M | 17.00% | 13,365,467 | - |
| 489 | TRAW | Traws Pharma, Inc. | 15.42M | 10.29% | 21,774 | 2.85M |
| 490 | OSRH | OSR Holdings, Inc. | 15.40M | 13.42% | 1,302,225 | -90.52K |
| 491 | INTS | Intensity Therapeutics, Inc. | 14.88M | 3.15% | 10,540 | - |
| 492 | COCP | Cocrystal Pharma, Inc. | 14.57M | 5.70% | 10,480 | - |
| 493 | INAB | IN8bio, Inc. | 14.48M | 7.30% | 53,445 | - |
| 494 | PHIO | Phio Pharmaceuticals Corp. | 14.35M | 2.92% | 69,070 | - |
| 495 | GNTA | Genenta Science S.p.A. | 14.14M | -4.21% | 46,584 | - |
| 496 | ICU | SeaStar Medical Holding Corporation | 13.60M | -5.94% | 420,332 | 1.23M |
| 497 | HOTH | Hoth Therapeutics, Inc. | 13.33M | 6.48% | 78,921 | - |
| 498 | BCAB | BioAtla, Inc. | 13.18M | 3.31% | 261,418 | 11.00M |
| 499 | BCDA | BioCardia, Inc. | 13.13M | 3.45% | 22,004 | 3.00K |
| 500 | GTBP | GT Biopharma, Inc. | 12.86M | -1.62% | 329,666 | - |